- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01722409
A Better Choice for Patients Undergoing Endovascular Coil Embolization
June 23, 2015 updated by: Wen-fei Tan, China Medical University, China
Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization
The investigators designed a double-blind, randomized placebo-controlled study to determine the effects of dexmedetomidine on the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110001
- Wen-fei Tan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:18-65 years old ASA I or ASA II patients undergoing ECE treatment for intracranial aneurysms were included.
Exclusion Criteria:Patients were excluded based on the following parameters: older than 65 yrs, a history of mental illness, recent use of sedatives or analgesics and with sensation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: sevoflurane and saline infusion
After induction of general anesthesia, Group S received a placebo infusion of normal saline.
|
|
Experimental: sevoflurane and 0.5 μg/kg dexmedetomidine
After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.
|
After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.
Other Names:
|
Experimental: sevoflurane and 1 μg/kg dexmedetomidine
After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.
|
After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Observing the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.
Time Frame: At the end of the operation and 24 hours later
|
The time from termination of the general anesthetic to the time that the patient's eyes opened.
Anesthesiologists collected information on emergence agitation, postoperative nausea and vomiting for 24 hours after the surgery.
|
At the end of the operation and 24 hours later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
February 1, 2015
Study Registration Dates
First Submitted
November 3, 2012
First Submitted That Met QC Criteria
November 5, 2012
First Posted (Estimate)
November 6, 2012
Study Record Updates
Last Update Posted (Estimate)
June 25, 2015
Last Update Submitted That Met QC Criteria
June 23, 2015
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Intracranial Arterial Diseases
- Aneurysm
- Intracranial Aneurysm
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, General
- Anesthetics
- Analgesics, Non-Narcotic
- Platelet Aggregation Inhibitors
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Anesthetics, Inhalation
- Dexmedetomidine
- Sevoflurane
Other Study ID Numbers
- 20121009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Aneurysms
-
Icahn School of Medicine at Mount SinaiKaneka CorporationRecruitingIntracranial Aneurysms | Wide Neck Intracranial AneurysmsUnited States
-
Penumbra Inc.CompletedIntracranial Aneurysms | Peripheral AneurysmsUnited States
-
Microvention-Terumo, Inc.UnknownIntracranial Aneurysms | Wide Neck Bifurcation Intracranial AneurysmsUnited States, Denmark, Canada, Hungary, Germany, Turkey
-
Zhujiang HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang University; Xuanwu... and other collaboratorsUnknownUnruptured Intracranial Aneurysms | Ruptured Intracranial Aneurysms | Stent-Assisted Coiling | Non-Stent-Assisted Coiling | Craniotomy ClippingChina
-
Microvention-Terumo, Inc.Enrolling by invitationIntracranial AneurysmsUnited States
-
Zhuhai Tonbridge Medical Tech. Co., Ltd.CompletedIntracranial AneurysmsChina
-
Mercy Health OhioStryker NeurovascularUnknown
-
Penumbra Inc.CompletedIntracranial AneurysmsFrance
-
Dr. med. Julius DenglerCharite University, Berlin, GermanyUnknownIntracranial AneurysmsAustria, Finland, France, Germany, Italy, Japan, Netherlands, Russian Federation, Switzerland
-
Stryker NeurovascularCompletedIntracranial AneurysmsUnited States, Germany, Canada, Spain, Norway, Australia, China, France, Mexico, Turkey, United Kingdom
Clinical Trials on sevoflurane and 0.5 μg/kg dexmedetomidine
-
Sichuan Haisco Pharmaceutical Group Co., LtdSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityCompletedHealthy VolunteersChina
-
Haisco Pharmaceutical Group Co., Ltd.Completed
-
Tanta UniversityNot yet recruitingDexmedetomidine | Splenectomy | External Oblique Intercostal Plane BlockEgypt
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingChronic Obstructive Pulmonary Disease | Dexmedetomidine | Respiratory Function TestsChina
-
Haisco Pharmaceutical Group Co., Ltd.Completed
-
Trinomab Biotech Co., Ltd.TIGERMED AUSTRALIA PTY LIMITEDCompletedHealthy Adult SubjectsAustralia
-
Jiangsu HengRui Medicine Co., Ltd.CompletedBreast Cancer | Neutropenia | Febrile NeutropeniaChina
-
VBI Vaccines Inc.Clinical Trial Data Services, LLCCompletedCytomegalovirus InfectionsCanada
-
Swedish Orphan BiovitrumAmgenCompleted